Search - tctmd.com

Displaying 881 - 900 of 1375

Sort: Relevancy | Date

News Daily News

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

L.A. McKeown

April 09, 2019

News Daily News

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Michael O'Riordan

April 04, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

Presentation SIF 2019

When Lightning Strikes Twice

Presenter: Nadia Sutton

March 29, 2019

Presentation CIT 2019

Renal Denervation and Therapies for Hypertension

Presenter: Murray Esler

March 28, 2019

Presentation CIT 2019

Where I See the Ideal Role for Renal Denervation Therapies

Presenter: Tony Walton

March 28, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

Presentation ECHO/IMAGING 2019

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

Presenter: William R. Miranda

March 24, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Conference News ACC 2019

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

L.A. McKeown

March 21, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News EHRA 2019

High-Dose Nifedipine Tied to Higher Cardiac Arrest Risk

Todd Neale

March 18, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

Cardiometabolic Risk Factors May Boost Effects of Air Pollution, Chinese Study Says

L.A. McKeown

March 12, 2019

News Conference News

Yo-Yo Diets Linked to Poorer CV Health in Women

L.A. McKeown

March 07, 2019

News Conference News CRT 2019

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Yael L. Maxwell

March 06, 2019

News Daily News

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

Todd Neale

March 05, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

Advertisement

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

When Lightning Strikes Twice

Renal Denervation and Therapies for Hypertension

Where I See the Ideal Role for Renal Denervation Therapies

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

High-Dose Nifedipine Tied to Higher Cardiac Arrest Risk

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Cardiometabolic Risk Factors May Boost Effects of Air Pollution, Chinese Study Says

Yo-Yo Diets Linked to Poorer CV Health in Women

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content